Headlands Technologies’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.01M	Buy	199,415 +33,565	+20%	+$170K	0.12%	178
2025 Q1	$877K	Buy	165,850 +76,536	+86%	+$405K	0.1%	207
2024 Q4	$604K	Buy	89,314 +59,211	+197%	+$400K	0.06%	309
2024 Q3	$198K	Buy	30,103 +7,011	+30%	+$46.2K	0.02%	523
2024 Q2	$173K	Buy	+23,092	New	+$173K	0.02%	511